Kiora Pharmaceuticals, Inc. (KPRX)
2.48
-0.04
(-1.59%)
USD |
NASDAQ |
Apr 21, 15:23
Kiora Pharmaceuticals EPS Diluted (Quarterly) : -1.732 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
| Cell Source, Inc. | -0.0153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.516M |
| Total Expenses (Quarterly) | 6.516M |
| Enterprise Value | -6.765M |
| Earnings Yield | -112.3% |
| Normalized Earnings Yield | -85.54 |